RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
University Health Network, Toronto
Valerio Therapeutics
Valerio Therapeutics